Daniel C.

Daniel C. is a highly experienced professional in the clinical diagnostics sector, currently serving as the Accounts Manager for Molecular Diagnostics Platform & Applications at QIAGEN since January 2022. Prior to this role, Daniel worked at Luminex Corporation, where responsibilities included sales and field applications management from 2016 to 2022, and at NanoString Technologies, focusing on global clinical market and product management from 2014 to 2016. Daniel's earlier experience includes sales and account management roles at Cepheid from 2010 to 2014, and significant project management and technical leadership positions at Roche Diagnostics from 2000 to 2009, encompassing R&D and sales functions. Daniel holds an MBA in Business Administration with a focus on Product Management and Marketing from the UW Foster School of Business, as well as a degree in Molecular, Cellular, and Developmental Biology from the University of California, Santa Cruz.